[Telemonitoring of patients with chronic respiratory failure in France].
La télésurveillance du patient insuffisant respiratoire chronique en France : l’opportunité d’organiser une prise en charge efficiente.
Chronic respiratory failure
Insuffisance respiratoire chronique
Non-invasive ventilation
Oxygen therapy
Oxygénothérapie
Telemonitoring
Télésurveillance
Ventilation non invasive
Journal
Revue des maladies respiratoires
ISSN: 1776-2588
Titre abrégé: Rev Mal Respir
Pays: France
ID NLM: 8408032
Informations de publication
Date de publication:
Sep 2023
Sep 2023
Historique:
received:
07
10
2022
accepted:
12
05
2023
medline:
11
9
2023
pubmed:
12
6
2023
entrez:
11
6
2023
Statut:
ppublish
Résumé
The year 2023 is marked by the officialization in French law of medical telemonitoring. Adult patients suffering from severe chronic respiratory failure (CRF) and being treated non-invasive ventilation (NIV) and/or oxygen therapy in a home setting are eligible for telemonitoring, of which the costs are to be covered by French health insurance. Telemonitoring allows a medical professional to remotely interpret the data necessary for follow-up and, if necessary, to make decisions regarding management of a given patient. Its objectives are, at the very least, to stabilize the disease through appropriate monitoring, to improve efficiency and quality of care, and to improve that patient's quality of life. The objective of this synthesis is to review the current state of remote monitoring of CRF patients by identifying, through a narrative analysis of the literature, its current benefits and limitations, and to compare present-day telemonitoring with the guidelines of the official French health authority (Haute Autorité de santé) for its nationwide application.
Identifiants
pubmed: 37302904
pii: S0761-8425(23)00172-9
doi: 10.1016/j.rmr.2023.05.002
pii:
doi:
Types de publication
English Abstract
Journal Article
Review
Langues
fre
Sous-ensembles de citation
IM
Pagination
623-629Informations de copyright
Copyright © 2023 SPLF. Published by Elsevier Masson SAS. All rights reserved.